Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...
Business Wire5d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13 th International RSV Symposium
Repeat infections with RSV are believed to be common ... from a targeted pathogen in a proprietary parainfluenza virus 5 vector. Clinical data have shown that administration of our intranasal ...
Morningstar5d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
Respiratory syncytial virus (RSV) is a highly contagious and ... from a targeted pathogen in a proprietary parainfluenza virus 5 vector. Clinical data have shown that administration of our ...
mlive4d
Still ‘no red flags’ for COVID vaccine after years of monitoring their safety
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
BioSpace5d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
Respiratory syncytial virus (RSV) is a highly contagious and common respiratory ... by expressing a protein from a targeted pathogen in a proprietary parainfluenza virus 5 vector. Clinical data have ...
pharmaphorum2d
A history of AstraZeneca
Arrow Therapeutics focused exclusively on novel antiviral drug discovery and development, including several different approaches towards Hepatitis C and Respiratory Syncytial Virus (RSV).
RSV hospitalization risk among older adults linked to age and certain risk conditions
Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...
News-Medical.Net on MSN2d
RSV hospitalization rates rise with age and chronic conditions in older adults
Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...
Yahoo Finance4d
Report: RSV-associated Hospitalisation Costs in Singapore Estimated at SGD 9,430 per Patient; Poses Financial Strain on At-risk Older Adults
Amongst the APEC countries and regions in the survey, hospitalisation costs per older adult in Singapore amounted to SGD 9,430 (USD 7,037),* as compared to Australia at SGD 7,757 (USD 5,789) * and ...
manilatimes4d
Report: RSV-associated Hospitalisation Costs in Singapore Estimated at SGD 9,430 per Patient; Poses Financial Strain on At-risk Older Adults
Hong Kong had a slightly higher cost at SGD 7,848 (USD 10,515) * compared to Singapore's. RSV, a common and contagious virus that affects the lungs and respiratory airways, that can affect people of ...
The Michigan Daily4d
COVID-19, influenza, RSV, bird flu and norovirus outbreaks converge across the U.S. and UMich campus
Five simultaneous outbreaks of norovirus, birdflu, influenza, COVID-19 and respiratory syncytial virus are occurring across the county, putting a strain on health care systems nationwide. Norovirus ...